Chaplain G, Grosclaude P, Arveux P, Raverdy N, Menegoz F, Henry-Amar M, Schaffer P, Daures J P, de Vathaire F
Registre des cancers gynécologiques de Côte-d'Or, Centre d'épidémiologie de population, Faculté de médecine, Dijon.
Bull Cancer. 1997 Oct;84(10):935-40.
The aim of the study was to assess the incident number of female breast and genital tract cancers for the whole of France. The study focused on the 1983-1987 period and on 9.1% of the French population. The incident number of female breast and genital tract cancers was estimated for each site and for each of eight French administrative regions covered by a cancer registry qualified through the National Committee of Registries (Calvados, Côte-d'Or, Doubs, Hérault, Isère, Bas-Rhin, Somme, Tarn). Information on mortality rates was available at a regional level as well as at a nationwide level. The method estimated the national incidence rate modelizing the regional age-specific incidence rate as a function of corresponding mortality rate. Breast cancer was the leading site with 25,277 new cases per year while female genital tract cancers affected about 13,856 women. The cancer risk, estimated in using cumulative rate 0-74 years, was assessed at 7.1% for breast and at 1.2%, 1.4% and 1.1% for cervix uteri, corpus uteri and ovary respectively. Breast and genital tract cancers constituted 49% of the whole of cancers in women. Observed breast incidence rate was stable through French regions. There were pronounced contrasts in cervix uteri cancer risk, and some french regions displayed a high risk close to the observed European maxima. Interregional contrasts in risk of the other genital tract cancers were less striking. This study emphasized the importance of female breast and genital tract cancers for public health in France. The main aim of the French Cancer Registries Network is to provide a comprehensive description of cancer risk in France and to produce pertinent projection to 2005 horizon, combining the present data and the already accumulated 1988-1992 data.
该研究的目的是评估整个法国女性乳腺癌和生殖道癌的发病数量。该研究聚焦于1983 - 1987年期间以及9.1%的法国人口。针对通过国家登记委员会认证的癌症登记处覆盖的法国八个行政区中的每一个以及每个部位,估算了女性乳腺癌和生殖道癌的发病数量(卡尔瓦多斯省、科多尔省、杜省、埃罗省、伊泽尔省、下莱茵省、索姆省、塔恩省)。区域层面和全国层面都有死亡率信息。该方法通过将区域年龄别发病率作为相应死亡率的函数进行建模来估算全国发病率。乳腺癌是主要发病部位,每年有25277例新发病例,而女性生殖道癌影响了约13856名女性。使用0 - 74岁累积发病率估算的癌症风险,乳腺癌为7.1%,子宫颈癌、子宫体癌和卵巢癌分别为1.2%、1.4%和1.1%。乳腺癌和生殖道癌占女性所有癌症的49%。法国各地区观察到的乳腺癌发病率稳定。子宫颈癌风险存在显著差异,一些法国地区显示出接近观察到的欧洲最高值的高风险。其他生殖道癌风险的区域间差异不太明显。这项研究强调了女性乳腺癌和生殖道癌对法国公共卫生的重要性。法国癌症登记网络的主要目标是结合当前数据和1988 - 1992年已积累的数据,全面描述法国的癌症风险并对2005年进行相关预测。